May 2011

The Princes of Asturias receive the recipients of the aids in the Palacio de la Zarzuela The research group of neurometabolic diseases of IDIBELL led by the ICREA researcher Aurora Pujol will receive a grant of 45,000 euros for a research project on X -linked adrenoleukodystrophy.

The researcher Gianluigi Giannelli of the University of Bari, Italy, focuses its research on studying the molecular mechanisms responsible for the progression of tumors, especially hepatic ones, and the identification of new therapeutic targets. Giannelli explained at a conference in the framework of the seminars IDIBELL, on 20 May that this must be the correct

An international study led by researchers at the Institute of Biomedical Research of Bellvitge (IDIBELL) has identified a new gene involved in susceptibility of developing breast cancer. Article’s reference Evidence for a link between TNFRSF11A and risk of Breast Cancer.

IDIBELL researchers demonstrate for the first time that inhibition of NADPH oxidases pathway slows the growth of tumor cells in vitro A study realized by researchers at the IDIBEL has shown that a drug that is under evaluation for cardiovascular disease, VAS2870, inhibits in vitro the enzymes of the family of NADPH oxidases in liver tumor cells. So it is able to reduce cell growth and regain the ability of the cell to self-destruct (apoptosis) in response to TGF-beta factor. The study results were published at the journal Biochemical Pharmacology. NADPH oxidases Article reference

“La nueva Ley de Ciencia nace sin presupuesto”

Cardiac regeneration could lead us to create bio-artificial hearts obtained from decellularized hearts and recomposed again with adult stem cells. This is the aim of the researcher and chief of cardiology at the Hospital Gregorio Maranon, Madrid, Francisco Fernández Avilés, who explained their latest advances in a new session of the seminars of IDIBELL on 13 May.

IDIBELL offers 12 positions for students to complete their formation during the summer months

This is the aim of metabolic engineering laboratory and diabetes at the Institute for Research in Biomedicine of Barcelona (IRBB) led by the center director, Joan Guinovart. The researcher explained on 6 May in the framework of the seminars of IDIBELL how accumulation of glycogen may be beneficial in some tissues such as liver and harmful in cells such as neurons where it can be lethal.

The Bellvitge University Hospital has organized on 2 and 3 May, the VIII International Course of Metabolic and Bariatric Laparoscopic Surgery with the assistance of national and international leading experts.

In the study, published and selected as a featured article in the journal Cell Group The American Journal of Human Genetics, also have participated Albert Martinez, researcher at Institute for Research in Biomedicine (IRB Barcelona) and Virginia Nunes, professor at UB and IDIBELL researcher. More information: http://www.ub.edu/web/ub/ca/menu_eines/noticies/2011/05/009.html